Intellewave, LLC strives to provide physicians with most effective solutions for quantitative assessment of the autonomic nervous system based on heart rate variability analysis. The company was founded in 2005, and started development of the Intellewave Heart Rate Variability system, which later became a technological breakthrough in clinical practice. The product was granted FDA clearance in October of 2006, and was launched on the market in February, 2007. The Intellewave system is the only device available on the market today to provide highly precise, fully automatic analysis of Heart Rate Variability, and is the first to deliver this convenient method of assessment to the physician's office. This unique system, based on artificial intelligence technology, helps physicians to recognize up to 81 types in relationships between sympathetic and parasympathetic branches of the autonomic nervous system. By combining these results with other clinical data, a doctor can optimize treatment programs and improve patient care.